Copyright Reports & Markets. All rights reserved.

Global Hypoactive Sexual Desire Disorder Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Hypoactive Sexual Desire Disorder Medication
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hypoactive Sexual Desire Disorder Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral
    • 1.3.3 Parenteral
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hypoactive Sexual Desire Disorder Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Online Pharmacy
    • 1.4.4 Retail Pharmacy
  • 1.5 Global Hypoactive Sexual Desire Disorder Medication Market Size & Forecast
    • 1.5.1 Global Hypoactive Sexual Desire Disorder Medication Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Hypoactive Sexual Desire Disorder Medication Sales Quantity (2018-2029)
    • 1.5.3 Global Hypoactive Sexual Desire Disorder Medication Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sprout Pharmaceuticals, Inc.
    • 2.1.1 Sprout Pharmaceuticals, Inc. Details
    • 2.1.2 Sprout Pharmaceuticals, Inc. Major Business
    • 2.1.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.1.4 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sprout Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.2 Covis Pharma GmbH
    • 2.2.1 Covis Pharma GmbH Details
    • 2.2.2 Covis Pharma GmbH Major Business
    • 2.2.3 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.2.4 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Covis Pharma GmbH Recent Developments/Updates
  • 2.3 Mylan N.V.
    • 2.3.1 Mylan N.V. Details
    • 2.3.2 Mylan N.V. Major Business
    • 2.3.3 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.3.4 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mylan N.V. Recent Developments/Updates
  • 2.4 Teva Pharmaceutical Industries Ltd.
    • 2.4.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.4.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.4.3 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.4.4 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.5 Amneal Pharmaceuticals LLC.
    • 2.5.1 Amneal Pharmaceuticals LLC. Details
    • 2.5.2 Amneal Pharmaceuticals LLC. Major Business
    • 2.5.3 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.5.4 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Amneal Pharmaceuticals LLC. Recent Developments/Updates
  • 2.6 Zydus Group
    • 2.6.1 Zydus Group Details
    • 2.6.2 Zydus Group Major Business
    • 2.6.3 Zydus Group Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.6.4 Zydus Group Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Zydus Group Recent Developments/Updates
  • 2.7 Sun Pharmaceutical Industries Ltd
    • 2.7.1 Sun Pharmaceutical Industries Ltd Details
    • 2.7.2 Sun Pharmaceutical Industries Ltd Major Business
    • 2.7.3 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.7.4 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.8 Abbvie,Inc
    • 2.8.1 Abbvie,Inc Details
    • 2.8.2 Abbvie,Inc Major Business
    • 2.8.3 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.8.4 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Abbvie,Inc Recent Developments/Updates
  • 2.9 EndoCeutics, Inc.
    • 2.9.1 EndoCeutics, Inc. Details
    • 2.9.2 EndoCeutics, Inc. Major Business
    • 2.9.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.9.4 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 EndoCeutics, Inc. Recent Developments/Updates
  • 2.10 S1 BIOPHARMA INC.
    • 2.10.1 S1 BIOPHARMA INC. Details
    • 2.10.2 S1 BIOPHARMA INC. Major Business
    • 2.10.3 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Product and Services
    • 2.10.4 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 S1 BIOPHARMA INC. Recent Developments/Updates

3 Competitive Environment: Hypoactive Sexual Desire Disorder Medication by Manufacturer

  • 3.1 Global Hypoactive Sexual Desire Disorder Medication Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Hypoactive Sexual Desire Disorder Medication Revenue by Manufacturer (2018-2023)
  • 3.3 Global Hypoactive Sexual Desire Disorder Medication Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Hypoactive Sexual Desire Disorder Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Hypoactive Sexual Desire Disorder Medication Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Hypoactive Sexual Desire Disorder Medication Manufacturer Market Share in 2022
  • 3.5 Hypoactive Sexual Desire Disorder Medication Market: Overall Company Footprint Analysis
    • 3.5.1 Hypoactive Sexual Desire Disorder Medication Market: Region Footprint
    • 3.5.2 Hypoactive Sexual Desire Disorder Medication Market: Company Product Type Footprint
    • 3.5.3 Hypoactive Sexual Desire Disorder Medication Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hypoactive Sexual Desire Disorder Medication Market Size by Region
    • 4.1.1 Global Hypoactive Sexual Desire Disorder Medication Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Hypoactive Sexual Desire Disorder Medication Consumption Value by Region (2018-2029)
    • 4.1.3 Global Hypoactive Sexual Desire Disorder Medication Average Price by Region (2018-2029)
  • 4.2 North America Hypoactive Sexual Desire Disorder Medication Consumption Value (2018-2029)
  • 4.3 Europe Hypoactive Sexual Desire Disorder Medication Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Consumption Value (2018-2029)
  • 4.5 South America Hypoactive Sexual Desire Disorder Medication Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Hypoactive Sexual Desire Disorder Medication Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 5.2 Global Hypoactive Sexual Desire Disorder Medication Consumption Value by Type (2018-2029)
  • 5.3 Global Hypoactive Sexual Desire Disorder Medication Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 6.2 Global Hypoactive Sexual Desire Disorder Medication Consumption Value by Application (2018-2029)
  • 6.3 Global Hypoactive Sexual Desire Disorder Medication Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 7.2 North America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 7.3 North America Hypoactive Sexual Desire Disorder Medication Market Size by Country
    • 7.3.1 North America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Hypoactive Sexual Desire Disorder Medication Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 8.2 Europe Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 8.3 Europe Hypoactive Sexual Desire Disorder Medication Market Size by Country
    • 8.3.1 Europe Hypoactive Sexual Desire Disorder Medication Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Hypoactive Sexual Desire Disorder Medication Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Market Size by Region
    • 9.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder Medication Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 10.2 South America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 10.3 South America Hypoactive Sexual Desire Disorder Medication Market Size by Country
    • 10.3.1 South America Hypoactive Sexual Desire Disorder Medication Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Hypoactive Sexual Desire Disorder Medication Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Hypoactive Sexual Desire Disorder Medication Market Size by Country
    • 11.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder Medication Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Hypoactive Sexual Desire Disorder Medication Market Drivers
  • 12.2 Hypoactive Sexual Desire Disorder Medication Market Restraints
  • 12.3 Hypoactive Sexual Desire Disorder Medication Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hypoactive Sexual Desire Disorder Medication and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hypoactive Sexual Desire Disorder Medication
  • 13.3 Hypoactive Sexual Desire Disorder Medication Production Process
  • 13.4 Hypoactive Sexual Desire Disorder Medication Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hypoactive Sexual Desire Disorder Medication Typical Distributors
  • 14.3 Hypoactive Sexual Desire Disorder Medication Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hypoactive Sexual Desire Disorder Medication market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Hypoactive Sexual Desire Disorder Medication market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Hypoactive Sexual Desire Disorder Medication market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hypoactive Sexual Desire Disorder Medication market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hypoactive Sexual Desire Disorder Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hypoactive Sexual Desire Disorder Medication market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hypoactive Sexual Desire Disorder Medication
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hypoactive Sexual Desire Disorder Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sprout Pharmaceuticals, Inc., Covis Pharma GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Amneal Pharmaceuticals LLC., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Hypoactive Sexual Desire Disorder Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral
    Parenteral
    Others
    Market segment by Application
    Hospital Pharmacy
    Online Pharmacy
    Retail Pharmacy
    Major players covered
    Sprout Pharmaceuticals, Inc.
    Covis Pharma GmbH
    Mylan N.V.
    Teva Pharmaceutical Industries Ltd.
    Amneal Pharmaceuticals LLC.
    Zydus Group
    Sun Pharmaceutical Industries Ltd
    Abbvie,Inc
    EndoCeutics, Inc.
    S1 BIOPHARMA INC.
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hypoactive Sexual Desire Disorder Medication product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hypoactive Sexual Desire Disorder Medication, with price, sales, revenue and global market share of Hypoactive Sexual Desire Disorder Medication from 2018 to 2023.
    Chapter 3, the Hypoactive Sexual Desire Disorder Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hypoactive Sexual Desire Disorder Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hypoactive Sexual Desire Disorder Medication market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hypoactive Sexual Desire Disorder Medication.
    Chapter 14 and 15, to describe Hypoactive Sexual Desire Disorder Medication sales channel, distributors, customers, research findings and conclusion.

    Buy now